小肝癌ADC值与手术切除术后无瘤生存期的相关性分析

肝脏 ›› 2019, Vol. 24 ›› Issue (2): 155-157.

小肝癌ADC值与手术切除术后无瘤生存期的相关性分析

赵云龙

028000 内蒙古通辽市传染病院

收稿日期:2018-05-18 发布日期:2020-04-10
通讯作者: 赵云龙,Email:1228027395@qq.com

Received:2018-05-18 Published:2020-04-10

摘要/Abstract

摘要： 目的分析小肝癌ADC值与手术切除术后无瘤生存期的相关性。方法随访观察2010年12月至2017年1月通辽市传染病院手术切除初发小肝癌且术前1周~1月进行1.5T或3.0T MR扫描检查的病例,选取术后复查MR发现肝脏新发癌灶或随访时间>36个月复查MR肝脏无新发癌灶病例26例,应用GE AW4.6工作站测量病灶ADC和eADC值,进行统计学分析。结果 26例病例中1.5T MR检查患者15例,其中5例无瘤生存期≥36个月,6例无瘤生存期≥12个月且<36个月,4例无瘤生存期<12个月。3.0T MR检查患者11例,其中4例无瘤生存期≥36个月,4例无瘤生存期≥12个月且<36个月,3例无瘤生存期<12个月。1.5T MR检查患者无瘤生存期≥12个月且<36个月和<12个月组间eADC值差异有统计学意义(显著性99.4%);3.0T MR检查患者无瘤生存期≥12个月且<36个月和<12个月组间ADC值差异有统计学意义(显著性95%)。结论小肝癌ADC值和eADC值可用于手术切除术后无瘤生存期的预测。

关键词: 小肝癌, 无瘤生存期, ADC值, eADC值

赵云龙. 小肝癌ADC值与手术切除术后无瘤生存期的相关性分析[J]. 肝脏, 2019, 24(2): 155-157.

参考文献

[1] Shin SK, Kim YS, Choi SJ,et al.Characterization of small(≤3 cm)hepatic lesions with atypical enhancement feature and hypointensity in hepatobiliary phase of gadoxetic acid-enhanced MRI in cirrhosis: A STARD-compliant article. Medicine(Baltimore),2017,96:e7278.
[2] Zhao JK, Li XB, Zhang K,et al.Prediction of microvascular invasion of hepatocellular carcinoma with preoperative diffusion-weighted imaging: A comparison of mean and minimum apparent diffusion coefficient values. Medicine(Baltimore),2017,96:e7754.
[3] Zhu SC, Liu YH, Wei Y,et al.Intravoxel incoherent motion diffusion-weighted magnetic resonance imaging for predicting histological grade of hepatocellular carcinoma:Comparison with conventional diffusion-weighted imaging. World J Gastroente-rol,2018,24:929-940.
[4] 唐艳华,叶慧义.扩散加权成像在肝细胞癌中的应用. 中国医学影像学杂志,2016,24:234-237.
[5] 胡兴荣,覃大明,张丽君,等.扩散加权成像在局灶性肝脏病变的临床应用. 中国CT和MRI杂志,2016,14:69-72.
[6] Baliyan V, Das CJ, Sharma R,et al.Diffusion weighted imaging:Technique and applications. World J Radiol,2016,8:785-798.
[7] Shenoy-Bhangle A, Baliyan V, Kordbacheh H,et al.Diffusion weighted magnetic resonance imaging of liver:Principles,clinical applications and recent updates. World J Hepatol,2017,9:1081-1091.
[8] Vu LN, Morelli JN,Szklaruk J.Basic MRI for the liver oncologists and surgeons. J Hepatocell Carcinoma,2018,5: 37-50.
[9] Wang XJ, Zhang QQ, Wang YK,et al.Clinical Significance of Ubiquitin Specific Protease 7(UPS7) in Predicting Prognosis of Hepatocellular Carcinoma and its Functional Mechanisms. Med Sci Monit,2018:24 1742-1750.
[10] Petrizzo A, Mauriello A, Tornesello ML,et al.Cellular prognostic markers in hepatitis-related hepatocellular carcinoma. infect Agent Cancer,2018, 13:10.
[11] Taron J, Johannink J, Bitzer M,et al.Added value of diffusion-weighted imaging in hepatic tumors and its impact on patient management. Cancer Imaging,2018,18:10.